feed,title,long_url,short_url
Benzinga,Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications,https://www.benzinga.com/pressreleases/20/07/n16481509/hansa-biopharma-announces-exclusive-agreement-with-sarepta-therapeutics-to-develop-and-promote-iml,https://j.mp/2YS3g6e
